Home > > > > Report Detail

Global Foot and Mouth Disease (FMD) Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 06-Sep-2022
No. of pages: 132
Inquire Before Buying

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Foot and Mouth Disease (FMD) Vaccines market is projected to reach US$ 2001.8 million by 2028 from an estimated US$ 1155 million in 2022, at a CAGR of 9.6% during 2023 and 2028.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines.

The Foot and Mouth Disease (FMD) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Foot and Mouth Disease (FMD) Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Foot and Mouth Disease (FMD) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Jinyu Group

- Cavet Bio

- Indian Immunologicals

- Tecon Group

- CAHIC

- Shen Lian

- Biogenesis Bagó

- BIGVET Biotech

- Boehringer Ingelheim

- MSD Animal Health

- CEVA

- FGBI

- Bayer HealthCare

- Brilliant Bio Pharma

- VECOL

- Sanofi (Merial)

- VETAL

- BVI

- LIMOR

- ME VAC

- Agrovet

Product Type Insights

Global markets are presented by Foot and Mouth Disease (FMD) Vaccines type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Foot and Mouth Disease (FMD) Vaccines are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Foot and Mouth Disease (FMD) Vaccines Segment by Type

- Emergency Vaccines

- Conventional Vaccines

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Foot and Mouth Disease (FMD) Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Foot and Mouth Disease (FMD) Vaccines market.

Foot and Mouth Disease (FMD) Vaccines Segment by Application

- Cattle

- Pig

- Sheep and Goat

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Foot and Mouth Disease (FMD) Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Foot and Mouth Disease (FMD) Vaccines industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Foot and Mouth Disease (FMD) Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Foot and Mouth Disease (FMD) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Market by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep and Goat
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts
2.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2017-2028
2.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2017-2028
2.2 Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2022 Versus 2028
2.3 Foot and Mouth Disease (FMD) Vaccines Sales by Region (2017-2028)
2.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2017-2022
2.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2023-2028)
2.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2017-2028)
2.4 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2017-2022
2.4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2023-2028)
2.4.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2017-2028)
3 Global Foot and Mouth Disease (FMD) Vaccines by Manufacturers
3.1 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Sales
3.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturer (2017-2022)
3.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Revenue
3.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2017-2022)
3.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturer (2017-2022)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Foot and Mouth Disease (FMD) Vaccines Manufacturers Covered: Ranking by Revenue
3.4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution, Product Type
3.5.1 Foot and Mouth Disease (FMD) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
3.5.3 Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Jinyu Group
4.1.1 Jinyu Group Corporation Information
4.1.2 Jinyu Group Description, Business Overview
4.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Products Offered
4.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.1.6 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.1.7 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.1.8 Jinyu Group Recent Developments
4.2 Cavet Bio
4.2.1 Cavet Bio Corporation Information
4.2.2 Cavet Bio Description, Business Overview
4.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Products Offered
4.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.2.6 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.2.7 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.2.8 Cavet Bio Recent Developments
4.3 Indian Immunologicals
4.3.1 Indian Immunologicals Corporation Information
4.3.2 Indian Immunologicals Description, Business Overview
4.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Products Offered
4.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.3.6 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.3.7 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.3.8 Indian Immunologicals Recent Developments
4.4 Tecon Group
4.4.1 Tecon Group Corporation Information
4.4.2 Tecon Group Description, Business Overview
4.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Products Offered
4.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.4.6 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.4.7 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.4.8 Tecon Group Recent Developments
4.5 CAHIC
4.5.1 CAHIC Corporation Information
4.5.2 CAHIC Description, Business Overview
4.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Products Offered
4.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.5.5 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.5.6 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.5.7 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.5.8 CAHIC Recent Developments
4.6 Shen Lian
4.6.1 Shen Lian Corporation Information
4.6.2 Shen Lian Description, Business Overview
4.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Products Offered
4.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.6.6 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.6.7 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.6.8 Shen Lian Recent Development
4.7 Biogenesis Bagó
4.7.1 Biogenesis Bagó Corporation Information
4.7.2 Biogenesis Bagó Description, Business Overview
4.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Products Offered
4.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.7.6 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.7.7 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.7.8 Biogenesis Bagó Recent Development
4.8 BIGVET Biotech
4.8.1 BIGVET Biotech Corporation Information
4.8.2 BIGVET Biotech Description, Business Overview
4.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Products Offered
4.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.8.5 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.8.6 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.8.7 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.8.8 BIGVET Biotech Recent Development
4.9 Boehringer Ingelheim
4.9.1 Boehringer Ingelheim Corporation Information
4.9.2 Boehringer Ingelheim Description, Business Overview
4.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Products Offered
4.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.9.6 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.9.7 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.9.8 Boehringer Ingelheim Recent Development
4.10 MSD Animal Health
4.10.1 MSD Animal Health Corporation Information
4.10.2 MSD Animal Health Description, Business Overview
4.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Products Offered
4.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.10.5 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.10.6 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.10.7 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.10.8 MSD Animal Health Recent Development
4.11 CEVA
4.11.1 CEVA Corporation Information
4.11.2 CEVA Description, Business Overview
4.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Products Offered
4.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.11.5 CEVA Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.11.6 CEVA Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.11.7 CEVA Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.11.8 CEVA Recent Development
4.12 FGBI
4.12.1 FGBI Corporation Information
4.12.2 FGBI Description, Business Overview
4.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Products Offered
4.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.12.5 FGBI Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.12.6 FGBI Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.12.7 FGBI Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.12.8 FGBI Recent Development
4.13 Bayer HealthCare
4.13.1 Bayer HealthCare Corporation Information
4.13.2 Bayer HealthCare Description, Business Overview
4.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Products Offered
4.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.13.6 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.13.7 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.13.8 Bayer HealthCare Recent Development
4.14 Brilliant Bio Pharma
4.14.1 Brilliant Bio Pharma Corporation Information
4.14.2 Brilliant Bio Pharma Description, Business Overview
4.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Products Offered
4.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.14.6 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.14.7 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.14.8 Brilliant Bio Pharma Recent Development
4.15 VECOL
4.15.1 VECOL Corporation Information
4.15.2 VECOL Description, Business Overview
4.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Products Offered
4.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.15.5 VECOL Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.15.6 VECOL Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.15.7 VECOL Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.15.8 VECOL Recent Development
4.16 Sanofi (Merial)
4.16.1 Sanofi (Merial) Corporation Information
4.16.2 Sanofi (Merial) Description, Business Overview
4.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Products Offered
4.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.16.6 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.16.7 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.16.8 Sanofi (Merial) Recent Development
4.17 VETAL
4.17.1 VETAL Corporation Information
4.17.2 VETAL Description, Business Overview
4.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Products Offered
4.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.17.5 VETAL Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.17.6 VETAL Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.17.7 VETAL Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.17.8 VETAL Recent Development
4.18 BVI
4.18.1 BVI Corporation Information
4.18.2 BVI Description, Business Overview
4.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Products Offered
4.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.18.5 BVI Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.18.6 BVI Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.18.7 BVI Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.18.8 BVI Recent Development
4.19 LIMOR
4.19.1 LIMOR Corporation Information
4.19.2 LIMOR Description, Business Overview
4.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Products Offered
4.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.19.5 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.19.6 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.19.7 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.19.8 LIMOR Recent Development
4.20 ME VAC
4.20.1 ME VAC Corporation Information
4.20.2 ME VAC Description, Business Overview
4.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Products Offered
4.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.20.5 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.20.6 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.20.7 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.20.8 ME VAC Recent Development
4.21 Agrovet
4.21.1 Agrovet Corporation Information
4.21.2 Agrovet Description, Business Overview
4.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Products Offered
4.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.21.5 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales by Product in 2021
4.21.6 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales by Application in 2021
4.21.7 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Area in 2021
4.21.8 Agrovet Recent Development
5 Breakdown Data by Type
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2017-2028)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2017-2022)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2023-2028)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2017-2028)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2017-2028)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2017-2022)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2023-2028)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2017-2028)
5.3 Foot and Mouth Disease (FMD) Vaccines Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2017-2028)
6.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2017-2022)
6.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2023-2028)
6.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2017-2028)
6.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2017-2028)
6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2017-2022)
6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2023-2028)
6.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2017-2028)
6.3 Foot and Mouth Disease (FMD) Vaccines Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size YoY Growth 2017-2028
7.2 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
7.2.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2028)
7.2.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2028)
7.3 North America Foot and Mouth Disease (FMD) Vaccines Sales by Type
7.4 North America Foot and Mouth Disease (FMD) Vaccines Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Region
8.2.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2017-2028)
8.2.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2017-2028)
8.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type
8.4 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application
9 Europe
9.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size YoY Growth 2017-2028
9.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
9.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2028)
9.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2028)
9.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type
9.4 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application
10 Latin America
10.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size YoY Growth 2017-2028
10.2 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
10.2.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2028)
10.2.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2028)
10.3 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type
10.4 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2028)
11.2.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2028)
11.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type
11.4 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Foot and Mouth Disease (FMD) Vaccines Supply Chain Analysis
12.2 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials and Upstream Suppliers
12.3 Foot and Mouth Disease (FMD) Vaccines Clients Analysis
12.4 Foot and Mouth Disease (FMD) Vaccines Sales Channel and Sales Model Analysis
12.4.1 Foot and Mouth Disease (FMD) Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Foot and Mouth Disease (FMD) Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Foot and Mouth Disease (FMD) Vaccines Distributors
13 Market Dynamics
13.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
13.2 Foot and Mouth Disease (FMD) Vaccines Market Drivers
13.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
13.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Emergency Vaccines
Table 3. Major Manufacturers of Conventional Vaccines
Table 4. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2017-2022) & (M Doses)
Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 8. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturer (2017-2022) & (M Doses)
Table 11. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturer (2017-2022)
Table 12. Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Price (2017-2022) & (USD/K Doses)
Table 15. Ranking of Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2021)
Table 18. Foot and Mouth Disease (FMD) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Jinyu Group Corporation Information
Table 23. Jinyu Group Description and Business Overview
Table 24. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 25. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
Table 26. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 27. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 28. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 29. Jinyu Group Recent Development
Table 30. Cavet Bio Corporation Information
Table 31. Cavet Bio Description and Business Overview
Table 32. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 33. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
Table 34. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 35. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 36. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 37. Cavet Bio Recent Development
Table 38. Indian Immunologicals Corporation Information
Table 39. Indian Immunologicals Description and Business Overview
Table 40. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 41. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
Table 42. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 43. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 44. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 45. Indian Immunologicals Recent Development
Table 46. Tecon Group Corporation Information
Table 47. Tecon Group Description and Business Overview
Table 48. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 49. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
Table 50. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 51. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 52. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 53. Tecon Group Recent Development
Table 54. CAHIC Corporation Information
Table 55. CAHIC Description and Business Overview
Table 56. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 57. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
Table 58. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 59. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 60. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 61. CAHIC Recent Development
Table 62. Shen Lian Corporation Information
Table 63. Shen Lian Description and Business Overview
Table 64. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 65. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
Table 66. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 67. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 68. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 69. Biogenesis Bagó Corporation Information
Table 70. Biogenesis Bagó Description and Business Overview
Table 71. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 72. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
Table 73. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 74. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 75. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 76. BIGVET Biotech Corporation Information
Table 77. BIGVET Biotech Description and Business Overview
Table 78. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 79. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
Table 80. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 81. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 82. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 83. Boehringer Ingelheim Corporation Information
Table 84. Boehringer Ingelheim Description and Business Overview
Table 85. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 86. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
Table 87. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Product in 2021
Table 88. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Application in 2021
Table 89. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD) Vaccines by Geographic Area in 2021
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 93. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product
Table 94. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales Proportion of Foot and Mouth Disease (FMD)
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs